Birchview Capital, LP Diversified Active

Location: Burlington, VT

CIK: 0001618205 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Jun 30, 2025

Total Value: $115M (100.0% shares, 0.0% debt)

Holdings (61)

BMY BRISTOL-MYERS SQUIBB CO 30.8%
Value $35.5M Shares 686,182 Share Price $51.74 * Est. Cost/Share $44.70 Unrealized @ Report Date -2.3%
— BIODESIX INC 8.6%
Value $9.855M Shares 5,541,176 Share Price $1.78 Est. Cost/Share $5.70 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 5.3%
Value $6.158M Shares 400,400 Share Price $15.38 * Est. Cost/Share $27.98 Unrealized @ Report Date -40.4%
ELUT ELUTIA INC 4.4%
Value $5.034M Shares 1,321,215 Share Price $3.81 * Est. Cost/Share $5.84 Unrealized @ Report Date -33.2%
UTHR UNITED THERAPEUTICS CORP 3.1%
Value $3.583M Shares 10,000 Share Price $358.35 * Est. Cost/Share $93.09 Unrealized @ Report Date +262.9%
PRTA PROTHENA CORP PLC 3.0%
Value $3.506M Shares 209,574 Share Price $16.73 * Est. Cost/Share $37.67 Unrealized @ Report Date -42.9%
NBIX NEUROCRINE BIOSCIENCES INC 3.0%
Value $3.484M Shares 30,240 Share Price $115.22 * Est. Cost/Share $72.40 Unrealized @ Report Date +89.4%
CORT CORCEPT THERAPEUTICS INC 3.0%
Value $3.425M Shares 74,000 Share Price $46.28 * Est. Cost/Share $13.51 Unrealized @ Report Date +162.9%
HROW HARROW HEALTH INC 2.8%
Value $3.278M Shares 72,910 Share Price $44.96 * Est. Cost/Share $6.05 Unrealized @ Report Date +459.3%
— QUIDELORTHO CORP 2.7%
Value $3.083M Shares 67,619 Share Price $45.60 Est. Cost/Share $67.73 Unrealized @ Report Date —
FHTX FOGHORN THERAPEUTICS INC 2.6%
Value $2.988M Shares 320,930 Share Price $9.31 * Est. Cost/Share $16.56 Unrealized @ Report Date -56.3%
AXGN AXOGEN INC 2.4%
Value $2.762M Shares 197,000 Share Price $14.02 * Est. Cost/Share $7.40 Unrealized @ Report Date +49.4%
PHR PHREESIA INC 2.3%
Value $2.614M Shares 114,700 Share Price $22.79 * Est. Cost/Share $21.44 Unrealized @ Report Date +9.2%
STOK STOKE THERAPEUTICS INC 2.2%
Value $2.581M Shares 210,000 Share Price $12.29 * Est. Cost/Share $7.86 Unrealized @ Report Date +80.3%
PTGX PROTAGONIST THERAPEUTICS INC 1.9%
Value $2.16M Shares 48,000 Share Price $45.00 * Est. Cost/Share $33.79 Unrealized @ Report Date +19.6%
TVTX TRAVERE THERAPEUTICS INC 1.8%
Value $2.071M Shares 148,000 Share Price $13.99 * Est. Cost/Share $13.34 Unrealized @ Report Date -21.9%
MASI MASIMO CORP 1.8%
Value $2.037M Shares 15,280 Share Price $133.33 * Est. Cost/Share $81.54 Unrealized @ Report Date +42.3%
OVV OVINTIV INC 1.7%
Value $2M Shares 52,200 Share Price $38.31 * Est. Cost/Share $33.44 Unrealized @ Report Date +29.3%
DCGO DOCGO INC 1.5%
Value $1.71M Shares 515,000 Share Price $3.32 * Est. Cost/Share $4.81 Unrealized @ Report Date -29.4%
CSTL CASTLE BIOSCIENCES INC 1.4%
Value $1.654M Shares 58,000 Share Price $28.52 * Est. Cost/Share $22.75 Unrealized @ Report Date +11.9%
ALKS ALKERMES PLC 1.2%
Value $1.399M Shares 50,000 Share Price $27.99 * Est. Cost/Share $21.00 Unrealized @ Report Date +27.0%
EQT EQT CORPORATION 1.1%
Value $1.268M Shares 34,619 Share Price $36.64 * Est. Cost/Share $33.40 Unrealized @ Report Date 0.0%
ATEC ALPHATEC HOLDINGS INC 1.0%
Value $1.101M Shares 198,000 Share Price $5.56 * Est. Cost/Share $8.72 Unrealized @ Report Date -12.0%
KALV KALVISTA PHARMACEUTICALS INC 0.8%
Value $950K Shares 82,000 Share Price $11.58 * Est. Cost/Share $15.61 Unrealized @ Report Date -19.4%
— KINIKSA PHARMACEUTICALS LTD 0.7%
Value $750K Shares 30,000 Share Price $24.99 Est. Cost/Share $13.10 Unrealized @ Report Date —
TXG 10X GENOMICS INC 0.6%
Value $677K Shares 30,000 Share Price $22.58 * Est. Cost/Share $43.17 Unrealized @ Report Date -52.1%
HALO HALOZYME THERAPEUTICS INC 0.5%
Value $572K Shares 10,000 Share Price $57.24 Est. Cost/Share $51.20 Unrealized @ Report Date +12.0%
— ACCELERATE DIAGNOSTICS INC 0.5%
Value $556K Shares 325,239 Share Price $1.71 Est. Cost/Share $13.66 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.5%
Value $528K Shares 10,000 Share Price $52.80 * Est. Cost/Share $27.06 Unrealized @ Report Date +106.0%
INBX INHIBRX BIOSCIENCES INC 0.4%
Value $503K Shares 32,110 Share Price $15.66 * Est. Cost/Share $14.64 Unrealized @ Report Date -4.0%
KROS KEROS THERAPEUTICS INC 0.4%
Value $406K Shares 7,000 Share Price $58.07 * Est. Cost/Share $46.71 Unrealized @ Report Date +5.7%
APLS APELLIS PHARMACEUTICALS INC 0.4%
Value $404K Shares 14,000 Share Price $28.84 * Est. Cost/Share $39.43 Unrealized @ Report Date -6.1%
TMCI TREACE MEDICAL CONCEPTS INC 0.3%
Value $396K Shares 68,350 Share Price $5.80 * Est. Cost/Share $6.42 Unrealized @ Report Date 0.0%
XENE XENON PHARMACEUTICALS INC 0.3%
Value $394K Shares 10,000 Share Price $39.37 * Est. Cost/Share $30.24 Unrealized @ Report Date +33.3%
— KARYOPHARM THERAPEUTICS INC 0.3%
Value $390K Shares 469,832 Share Price $0.83 Est. Cost/Share $7.66 Unrealized @ Report Date —
CHRS COHERUS BIOSCIENCES INC 0.3%
Value $387K Shares 372,000 Share Price $1.04 * Est. Cost/Share $2.23 Unrealized @ Report Date -38.4%
ARVN ARVINAS INC 0.3%
Value $369K Shares 15,000 Share Price $24.63 * Est. Cost/Share $16.46 Unrealized @ Report Date +58.6%
PGNY PROGYNY INC 0.3%
Value $369K Shares 22,000 Share Price $16.76 * Est. Cost/Share $35.06 Unrealized @ Report Date -31.5%
— BIOHAVEN PHARMACEUTICAL HOLDING CO LTD 0.3%
Value $368K Shares 7,365 Share Price $49.97 Est. Cost/Share $42.80 Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC 0.3%
Value $359K Shares 4,000 Share Price $89.87 * Est. Cost/Share $83.94 Unrealized @ Report Date +4.0%
CGEM CULLINAN ONCOLOGY INC 0.3%
Value $335K Shares 20,000 Share Price $16.74 * Est. Cost/Share $40.60 Unrealized @ Report Date -56.3%
WVE WAVE LIFE SCIENCES LTD 0.3%
Value $328K Shares 40,000 Share Price $8.20 * Est. Cost/Share $5.34 Unrealized @ Report Date +11.8%
— SPRINGWORKS THERAPEUTICS INC 0.3%
Value $320K Shares 10,000 Share Price $32.04 Est. Cost/Share $36.50 Unrealized @ Report Date —
NVCR NOVOCURE LTD 0.3%
Value $313K Shares 20,000 Share Price $15.63 * Est. Cost/Share $17.59 Unrealized @ Report Date +3.1%
SRPT SAREPTA THERAPEUTICS INC 0.3%
Value $312K Shares 2,500 Share Price $124.89 * Est. Cost/Share $100.79 Unrealized @ Report Date +37.2%
BCRX BIOCRYST PHARMACEUTICALS INC 0.3%
Value $304K Shares 40,000 Share Price $7.60 Est. Cost/Share $5.77 Unrealized @ Report Date +31.8%
FOLD AMICUS THERAPEUTICS INC 0.3%
Value $299K Shares 28,000 Share Price $10.68 Est. Cost/Share $14.56 Unrealized @ Report Date -25.2%
— BLUEPRINT MEDICINES CORP 0.2%
Value $250K Shares 2,700 Share Price $92.50 Est. Cost/Share $92.50 Unrealized @ Report Date —
XNCR XENCOR INC 0.2%
Value $247K Shares 12,300 Share Price $20.11 * Est. Cost/Share $15.78 Unrealized @ Report Date +19.0%
GOSS GOSSAMER BIO INC 0.1%
Value $136K Shares 138,176 Share Price $0.99 Est. Cost/Share $5.35 Unrealized @ Report Date -82.0%
— BLUEBIRD BIO INC 0.1%
Value $110K Shares 211,200 Share Price $0.52 Est. Cost/Share $11.94 Unrealized @ Report Date —
ALMS ALUMIS INC 0.1%
Value $107K Shares 10,000 Share Price $10.68 * Est. Cost/Share $12.13 Unrealized @ Report Date 0.0%
LQDA LIQUIDIA CORPORATION 0.1%
Value $100K Shares 10,000 Share Price $10.00 * Est. Cost/Share $7.20 Unrealized @ Report Date +51.7%
QURE UNIQURE NV 0.1%
Value $98,600 Shares 20,000 Share Price $4.93 * Est. Cost/Share $6.51 Unrealized @ Report Date 0.0%
IFRX INFLARX NV 0.1%
Value $76,500 Shares 50,000 Share Price $1.53 Est. Cost/Share $3.70 Unrealized @ Report Date -58.9%
— 2SEVENTY BIO INC 0.1%
Value $74,732 Shares 15,833 Share Price $4.72 Est. Cost/Share $19.43 Unrealized @ Report Date —
VTYX VENTYX BIOSCIENCES INC 0.1%
Value $62,784 Shares 28,800 Share Price $2.18 * Est. Cost/Share $21.31 Unrealized @ Report Date -89.2%
ZNTL ZENTALIS PHARMACEUTICALS INC 0.1%
Value $58,880 Shares 16,000 Share Price $3.68 Est. Cost/Share $14.59 Unrealized @ Report Date -75.1%
CABA CABALETTA BIO INC 0.0%
Value $47,200 Shares 10,000 Share Price $4.72 * Est. Cost/Share $16.81 Unrealized @ Report Date -65.6%
— OUTSET MEDICAL INC 0.0%
Value $6,770 Shares 10,000 Share Price $0.68 Est. Cost/Share $3.85 Unrealized @ Report Date —
— CERO THERAPEUTICS HOLDINGS INC 0.0%
Value $1,210 Shares 12,972 Share Price $0.09 Est. Cost/Share $3.07 Unrealized @ Report Date —